HealthExperimental treatment could work against prion diseases like CJD Prion diseases are invariably fatal, but an experimental genetic treatment has dramatically extended the lifespans of infected mice News
HealthNew drug donanemab slows cognitive decline in early Alzheimer's The experimental treatment donanemab is now the second antibody drug to slow cognitive decline in people with early stage Alzheimer’s disease, but questions remain about its real-world benefits and safety News